1. Home
  2. Browse Decisions
  3. F.Supp.3d
  4. 439 F.Supp.3d
  5. 439 F.Supp.3d 388 (2020)
 

PURCELL v. GILEAD SCIENCES, INC.

CIVIL ACTION NO. 17-3523.

439 F.Supp.3d 388 (2020)

Chris PURCELL, et al. v. GILEAD SCIENCES, INC.

United States District Court, E.D. Pennsylvania.

Filed February 13, 2020.

Editors Note
Applicable Law: 31 U.S.C. § 3730
Cause: 31 U.S.C. § 3730 Qui Tam False Claims Act
Nature of Suit: 376 Qui Tam (31 U.S.C. § 3729(a))
Source: PACER

Attorney(s) appearing for the Case

Bradford L. Geyer , Cinnaminson, NJ, Rob Hennig , Hennig Ruiz & Singh, Los Angeles, CA, Robert E. Connolly , Law Office of Robert Connolly, Palm Springs, CA, for Chris Purcell, et al.

E. Joshua Rosenkranz , Orrick Herrington & Sutcliffe LLP, New York, NY, Molly Elizabeth Flynn , Faegre Drinker Biddle & Reath LLP, Philadelphia, PA, Randy Luskey , Orrick Herrington Sutcliffe LLP, San Francisco, CA, Tiffany R. Wright , Mel Bostwick , Sheila Baynes , Orrick Herrington & Sutcliffe LLP, Washington, DC, for Gilead Sciences, Inc.

MEMORANDUM

Congress prohibits pharmaceutical companies from compensating healthcare providers to induce them to prescribe often more expensive drugs paid by federal and state treasuries. Mindful of this bar, marketing to persuade healthcare providers to prescribe new drugs created after significant research...

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases